CA2735921C - Process for the synthesis of halogenated cyclic compounds - Google Patents

Process for the synthesis of halogenated cyclic compounds Download PDF

Info

Publication number
CA2735921C
CA2735921C CA2735921A CA2735921A CA2735921C CA 2735921 C CA2735921 C CA 2735921C CA 2735921 A CA2735921 A CA 2735921A CA 2735921 A CA2735921 A CA 2735921A CA 2735921 C CA2735921 C CA 2735921C
Authority
CA
Canada
Prior art keywords
process according
formula
compound
alkyl group
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2735921A
Other languages
English (en)
French (fr)
Other versions
CA2735921A1 (en
Inventor
Max Braun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Solvay SA
Original Assignee
Solvay SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay SA filed Critical Solvay SA
Publication of CA2735921A1 publication Critical patent/CA2735921A1/en
Application granted granted Critical
Publication of CA2735921C publication Critical patent/CA2735921C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/803—Processes of preparation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
CA2735921A 2008-09-30 2009-09-25 Process for the synthesis of halogenated cyclic compounds Expired - Fee Related CA2735921C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08165547.4 2008-09-30
EP08165547 2008-09-30
PCT/EP2009/062462 WO2010037688A1 (en) 2008-09-30 2009-09-25 Process for the synthesis of halogenated cyclic compounds

Publications (2)

Publication Number Publication Date
CA2735921A1 CA2735921A1 (en) 2010-04-08
CA2735921C true CA2735921C (en) 2017-03-21

Family

ID=40351699

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2735921A Expired - Fee Related CA2735921C (en) 2008-09-30 2009-09-25 Process for the synthesis of halogenated cyclic compounds

Country Status (7)

Country Link
US (2) US8431710B2 (enExample)
EP (1) EP2334645B1 (enExample)
JP (5) JP6180705B2 (enExample)
KR (3) KR20110066201A (enExample)
CN (2) CN102164898A (enExample)
CA (1) CA2735921C (enExample)
WO (1) WO2010037688A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2310350B1 (en) 2008-07-04 2017-09-06 Solvay Sa Process for the manufacture of alkenones
KR20110066201A (ko) 2008-09-30 2011-06-16 솔베이(소시에떼아노님) 할로겐화 환형 화합물의 합성 방법
GB0903749D0 (en) * 2009-03-04 2009-04-15 Syngenta Participations Ag Chemical process
US8957254B2 (en) 2009-07-06 2015-02-17 Solvay Sa Process for chemical synthesis from an alkenone made from a halogenated precursor
MX2012000379A (es) 2009-07-06 2012-03-07 Solvay Proceso para la fabricacion de precursores halogenados de alquenonas en presencia de un solvente.
EP2662359A1 (en) 2012-05-08 2013-11-13 Solvay Sa Ionic Liquids, Method for manufacturing thereof, and Electrochemical Devices Comprising the Same
CN104583167B (zh) * 2012-08-22 2017-09-19 索尔维公司 用于制备烯酮的方法
MY170539A (en) 2012-12-20 2019-08-15 Solvay Salts of n-containing heterocyclic anions as components in electrolytes
US20160137624A1 (en) * 2013-06-20 2016-05-19 Basf Se Process for preparing pyridylpyrazole compounds and derivatives thereof from pyridylhydrazine
EP2987782A1 (en) 2014-08-22 2016-02-24 Solvay SA Distillation process comprising at least two distillation steps to obtain purified halogenated carboxylic acid halide, and use of the purified halogenated carboxylic acid halide
WO2016079122A1 (en) 2014-11-17 2016-05-26 Solvay Sa A method for producing a chemical compound and apparatus therefor
CN107001231A (zh) 2014-11-17 2017-08-01 索尔维公司 包括至少两个蒸馏步骤以获得纯化的卤化的羧酸卤化物的蒸馏方法、以及该纯化的卤化的羧酸卤化物的用途
EP3031791A1 (en) 2014-12-10 2016-06-15 Solvay SA Halogenation process of 1,1-dihaloethene
EP3199522A1 (en) 2016-02-01 2017-08-02 Solvay SA Aminothioate derivatives, production thereof and use
JP2020532524A (ja) 2017-09-04 2020-11-12 ソルヴェイ（ソシエテ アノニム） ジフルオロアセチルクロリドの製造方法及び製造中間体
JP6911143B2 (ja) 2018-11-07 2021-07-28 福建永晶科技股▲ふん▼有限公司Ｆｕｊｉａｎ Ｙｏｎｇｊｉｎｇ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏ．， Ｌｔｄ ピラゾール又はピリミジノンの新しい製造方法
US11390587B2 (en) * 2018-12-27 2022-07-19 Corteva Agriscience Llc Preparation of sulfonamide herbicide process intermediates
JP2023512000A (ja) 2020-01-31 2023-03-23 ソルヴェイ（ソシエテ アノニム） ハロアルキル置換ピリジン化合物の製造のプロセス
JP2021079146A (ja) * 2021-02-22 2021-05-27 株式会社三洋物産 遊技機
JP7315071B2 (ja) * 2021-03-03 2023-07-26 株式会社三洋物産 遊技機

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3420166A1 (de) * 1984-05-30 1985-12-05 Basf Ag, 6700 Ludwigshafen Pyrimidylphosphorsaeureester, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von schaedlingen
CA2105489A1 (en) 1991-03-07 1992-09-08 Tariq Arthur Andrea Herbicidal pyridine sulphonamide
US5235060A (en) 1991-07-11 1993-08-10 E. I. Du Pont De Nemours And Company Certain three component ionic substituted pyridine compounds as intermediates for preparation as herbicides
DE4128828A1 (de) 1991-08-30 1993-03-04 Basf Ag Ammonium- oder harnstoffhaltige duengemittel und verfahren zu ihrer herstellung
EP0664805A1 (en) 1992-10-13 1995-08-02 Smithkline Beecham Plc Heterocyclic -esters or -amides used as 5-ht 4? receptor antagonists
EP0659729B1 (de) 1993-12-23 1998-06-24 Solvay Fluor und Derivate GmbH Verfahren zur Herstellung von Polyfluorchlor- und Perfluorcarbonsäurechloriden unter Chlorzusatz
JP3843152B2 (ja) * 1995-08-08 2006-11-08 石原産業株式会社 ４−アルコキシ−１，１，１−トリフルオロ−３−ブテン−２−オンの製造方法
GB2305174A (en) * 1995-09-15 1997-04-02 Zeneca Ltd Chemical process
GB9711114D0 (en) * 1997-05-29 1997-07-23 Merck Sharp & Dohme Therapeutic agents
DE19821088A1 (de) 1998-05-12 1999-11-18 Basf Ag Modifizierte Polykondensate der Asparaginsäure, Verfahren zu ihrer Herstellung und ihre Verwendung in Düngemitteln
WO2002053518A2 (en) 2000-12-29 2002-07-11 Honeywell International, Inc. HALOGENATED-α,β-UNSATURATED-β-(SUBSTITUTED-AMINO) CARBOXYLATE ESTERS
ES2318275T3 (es) 2003-03-07 2009-05-01 Syngenta Participations Ag Procedimiento para la produccion de esteres del acido niocotinico sustituidos.
DE10325715A1 (de) * 2003-06-06 2004-12-23 Solvay Fluor Und Derivate Gmbh Vereinfachte Herstellung von Alkenonen
US20060128702A1 (en) 2004-11-23 2006-06-15 Manojit Pal Heterocyclic and bicyclic compounds, compositions and methods
DE102004061593A1 (de) 2004-12-21 2006-06-22 Abbott Gmbh & Co. Kg Substituierte N-heterocyclische Verbindungen und ihre therapeutische Verwendung
KR20080048502A (ko) 2005-09-29 2008-06-02 머크 앤드 캄파니 인코포레이티드 멜라노코르틴-4 수용체 조절제로서의 아실화스피로피페리딘 유도체
EP1982978B1 (en) * 2006-02-02 2014-08-27 Kumiai Chemical Industry Co., Ltd. Pyridone derivative and herbicide
EP2422790A1 (en) * 2007-02-09 2012-02-29 Emory University Paramyxovirus family inhibitors and methods of use thereof
EP1987717A1 (de) * 2007-04-30 2008-11-05 Bayer CropScience AG Pyridoncarboxamide, diese enthaltende nutzpflanzenschützende Mittel und Verfahren zu ihrer Herstellung und deren Verwendung
EP2008996A1 (en) * 2007-06-27 2008-12-31 Syngeta Participations AG Process for the production of pyrazoles
MX2011000196A (es) 2008-07-01 2011-03-24 Dow Agrosciences Llc Proceso mejorado para la preparacion de alquilpiridinas 2-trifluorometil-5-(1-sustituidas).
EP2310350B1 (en) 2008-07-04 2017-09-06 Solvay Sa Process for the manufacture of alkenones
EP2154167A1 (de) * 2008-07-30 2010-02-17 Bayer MaterialScience AG Elektromechanischer Wandler mit einem Polymerelement auf Polyisocyanat-Basis
KR20110066201A (ko) 2008-09-30 2011-06-16 솔베이(소시에떼아노님) 할로겐화 환형 화합물의 합성 방법
MX2012000379A (es) 2009-07-06 2012-03-07 Solvay Proceso para la fabricacion de precursores halogenados de alquenonas en presencia de un solvente.
MX2012000381A (es) 2009-07-06 2012-03-07 Solvay Proceso para la fabricacion de precursores halogenados de alquenonas bajo condiciones especificas.
US8440865B2 (en) 2009-07-06 2013-05-14 Solvay Sa Process for the manufacture of alkenones
JP6194245B2 (ja) * 2013-12-27 2017-09-06 株式会社Ｓｕｂａｒｕ 信号機認識装置

Also Published As

Publication number Publication date
CA2735921A1 (en) 2010-04-08
JP2015227339A (ja) 2015-12-17
JP6647268B2 (ja) 2020-02-14
US20130237710A1 (en) 2013-09-12
US8431710B2 (en) 2013-04-30
CN106083710A (zh) 2016-11-09
JP2012504153A (ja) 2012-02-16
JP2022028792A (ja) 2022-02-16
US20110178297A1 (en) 2011-07-21
KR20160131129A (ko) 2016-11-15
EP2334645B1 (en) 2019-11-06
JP2020023533A (ja) 2020-02-13
US8981115B2 (en) 2015-03-17
KR20110066201A (ko) 2011-06-16
CN102164898A (zh) 2011-08-24
JP6180705B2 (ja) 2017-08-16
WO2010037688A1 (en) 2010-04-08
JP2018058869A (ja) 2018-04-12
KR20190080972A (ko) 2019-07-08
JP6511346B2 (ja) 2019-05-15
CN106083710B (zh) 2021-03-12
EP2334645A1 (en) 2011-06-22

Similar Documents

Publication Publication Date Title
US8981115B2 (en) Process for the synthesis of halogenated cyclic compounds
IL185885A (en) Method for the preparation of 2-cyclopropyl and 2-phenyl 1,6-dihydro-6-oxo-4-pyrimidine Carboxylic acids are converted according to choice and intermediates
JP3670314B2 (ja) １−置換−５（４ｈ）−テトラゾリノン類の製造方法
EP0965589B1 (en) Process and intermediates for the manufacture of pyridine-2,3-dicarboxylate compounds
WO1999044969A1 (en) Methods for highly selectively o-alkylating amide compounds with the use of copper salts
EP0899262B1 (en) Process for the preparation of heteroarylcarboxylic amides and esters
EP2257530A1 (en) Process for preparing substituted biphenylanilides
US6320053B1 (en) Preparation of heteroarylcarboxamides
US6080867A (en) Process and intermediates for the manufacture of pyridine-2,3-dicarboxylate compounds
JP4879907B2 (ja) フェニル２−ピリミジニルケトン類の製造方法及びその新規中間体
TWI404711B (zh) ２-烯基-３-胺基噻吩衍生物及其製造方法
JP2991832B2 (ja) ピリミジン誘導体の製造方法
CN110352193A (zh) 制备4-[(4,5-二氢-3-甲氧基-4-甲基-5-氧代-1h-1,2,4-三唑-1-基)羰基)氨磺酰基]-5-甲基噻吩-3-甲酸甲酯的方法
MX2007013892A (es) Proceso para la preparacion de 5-alquiltioalquilamino-1-fenil- pirazoles.

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20140825

MKLA Lapsed

Effective date: 20200925